| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eccd894c99fea2d1c0c8735872bb2309 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-844 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-243
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2818
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2827
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-179
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-71 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-71 |
| filingDate |
2019-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee35985dcb697c9d4bbc9f4325348d69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0efd24badf9c1065c8fc884347e18e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1974da2bdc9f47ff8392263813a1c1bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05faeef0ad090da61b6bf755d4ddb2c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce8046b9780eaa5caca6c0b30210a1ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6147ec73eef3b73b915cc1f14818bdcf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5b836fc88a81bdad528e6dfd84f55c4 |
| publicationDate |
2021-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3810654-A1 |
| titleOfInvention |
Dosing regimens for targeted tgf-b inhibition for use in treating biliary tract cancer |
| abstract |
This disclosure relates to dosage regimens for targeted TGF-β inhibition with a bi-functional fusion protein for use in a method of treating biliary tract cancer or inhibiting biliary tract tumor growth in treatment naive patients, or patients with locally advanced or metastatic BTC who have failed or are intolerant to first-line systemic chemotherapy. |
| priorityDate |
2018-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |